Table 2.
Characteristic | P value |
---|---|
Race | 0.287 |
Increasing tumor grade | 0.015 |
Clinical T stage | 0.231 |
ER / PR negative status | 0.00002 |
HER-2/neu amplification | 0.025 |
Clinical N0 nodal status | < 0.0001 |
Use of chemotherapy vs. endocrine therapy | 0.081 |